Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOLUPRIM: HIV-RNA Decay in Seminal Plasma
NCT02976259Phase 3Completed
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV). Started Jan 2017; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02976259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976259.